Luvox 100 100 mg. FC tablets.
PDF Leaflet Revision Date: 13 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive episodes and obsessive-compulsive disorder in adults.
Dosage (summary)
Starting dose: 100 mg/day; max: 300 mg/day, adjust based on response.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- MAOIs
- Tizanidine
- Pimozide
- Lithium
- Oral anticoagulants
Contraindications
- Hypersensitivity to fluvoxamine
- Pregnancy
- Lactation
- Under 18 years
- Liver dysfunction
- Epilepsy
Common side effects
- Nausea
- Dizziness
- Somnolence
- Agitation
- Palpitations
Counselling Points
- Monitor for suicidal thoughts
- Avoid alcohol
- Gradual tapering recommended when discontinuing
Serious warnings
- Risk of suicidal thoughts
- Serotonin syndrome
- Akathisia
Important Disclaimer
The Luvox 100 100 mg. FC tablets. professional information leaflet below is the property of Abbott Laboratories South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
